A new trading day began on Friday, with Relay Therapeutics Inc (NASDAQ: RLAY) stock price up 3.24% from the previous day of trading, before settling in for the closing price of $4.32. RLAY’s price has ranged from $3.50 to $11.16 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 399.77%. Meanwhile, its annual earnings per share averaged 9.80%. With a float of $123.45 million, this company’s outstanding shares have now reached $166.89 million.
Let’s determine the extent of company efficiency that accounts for 323 employees. In terms of profitability, gross margin is 58.64%, operating margin of -3926.55%, and the pretax margin is -3449.92%.
Relay Therapeutics Inc (RLAY) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Relay Therapeutics Inc is 26.25%, while institutional ownership is 73.19%. The most recent insider transaction that took place on Jan 03 ’25, was worth 138,361. In this transaction an insider of this company sold 32,177 shares at a rate of $4.30, taking the stock ownership to the 325,330 shares. Before that another transaction happened on Jan 02 ’25, when Company’s insider sold 32,156 for $4.15, making the entire transaction worth $133,447. This insider now owns 357,507 shares in total.
Relay Therapeutics Inc (RLAY) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.61 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 9.80% per share during the next fiscal year.
Relay Therapeutics Inc (NASDAQ: RLAY) Trading Performance Indicators
Here are Relay Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 18.42. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 74.58.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.61, a number that is poised to hit -0.57 in the next quarter and is forecasted to reach -2.64 in one year’s time.
Technical Analysis of Relay Therapeutics Inc (RLAY)
Looking closely at Relay Therapeutics Inc (NASDAQ: RLAY), its last 5-days average volume was 3.71 million, which is a jump from its year-to-date volume of 3.49 million. As of the previous 9 days, the stock’s Stochastic %D was 24.50%. Additionally, its Average True Range was 0.50.
During the past 100 days, Relay Therapeutics Inc’s (RLAY) raw stochastic average was set at 13.30%, which indicates a significant decrease from 38.55% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 106.66% in the past 14 days, which was higher than the 97.42% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.77, while its 200-day Moving Average is $6.45. However, in the short run, Relay Therapeutics Inc’s stock first resistance to watch stands at $4.66. Second resistance stands at $4.87. The third major resistance level sits at $5.14. If the price goes on to break the first support level at $4.18, it is likely to go to the next support level at $3.91. Should the price break the second support level, the third support level stands at $3.70.
Relay Therapeutics Inc (NASDAQ: RLAY) Key Stats
With a market capitalization of 746.53 million, the company has a total of 167,383K Shares Outstanding. Currently, annual sales are 25,550 K while annual income is -341,970 K. The company’s previous quarter sales were 0 K while its latest quarter income was -92,210 K.
